Product Description
The global transcatheter mitral valve repair market was valued at $2.4 billion in 2025. This is expected to increase over the forecast period at a CAGR of 6.2% to reach $3.6 billion
The global transcatheter mitral valve repair market was valued at $2.4 billion in 2025. This is expected to increase over the forecast period at a CAGR of 6.2% to reach $3.6 billion
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Transcatheter Mitral Valve Repair Device Market Trends
As more companies enter the TMVr space, manufacturers are increasingly pursuing portfolio-based strategies that integrate repair, replacement, and adjunctive technologies. This trend is intensifying competitive pressure, accelerating innovation cycles, and driving partnerships and acquisitions aimed at addressing technology gaps. For example, Meril recently launched MyClip, India’s first transcatheter edge-to-edge repair (TEER) system for mitral valve repair, underscoring the expanding global participation and competitive dynamics within the TMVr market.
Transcatheter Mitral Valve Repair Device Market Share Insights
- Abbott was the leading competitor in the TMVr device market with a majority market share. The company’s TMVr system is the MitraClip®. The product was the world’s first TMVr device. Abbott is expected to maintain its market leadership over the forecast period as it continues to invest in the mitral valve treatment areas.
- Edwards Lifesciences was the second-leading competitor in the TMVr market. Edwards Lifesciences gained market share in 2019 with the PASCAL system to treat MR. The mitral repair device complements Edwards’s successful Sapien® aortic valve replacement system in its structural heart portfolio. Over the forecast period, Edwards Lifesciences is expected to gain some shares as it continues to invest in structural heart treatments.
- Cardiac Dimensions holds a notable share of the global TMVr market. Cardiac Dimensions offers the CARILLION® Mitral Contour System™. The system includes a proprietary, implantable device and a percutaneous catheter delivery system. Due to the notable nature and limited global presence, Cardiac Dimensions is not expected to see notable shifts in its market share over the forecast period.
Transcatheter Mitral Valve Repair Device Market Segmentation Summary
Transcatheter Mitral Valve Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
